Growth Metrics

Myr (MYRG) Cash & Equivalents (2016 - 2026)

Myr has reported Cash & Equivalents over the past 17 years, most recently at $163.2 million for Q1 2026.

  • Quarterly Cash & Equivalents rose 1397.72% to $163.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $163.2 million through Mar 2026, up 1397.72% year-over-year, with the annual reading at $150.2 million for FY2025, 4234.76% up from the prior year.
  • Cash & Equivalents was $163.2 million for Q1 2026 at Myr, up from $150.2 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $163.2 million in Q1 2026 and troughed at $1.9 million in Q2 2024.
  • The 5-year median for Cash & Equivalents is $23.0 million (2025), against an average of $40.8 million.
  • Year-over-year, Cash & Equivalents crashed 91.82% in 2024 and then soared 4234.76% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $51.0 million in 2022, then crashed by 51.22% to $24.9 million in 2023, then crashed by 86.09% to $3.5 million in 2024, then soared by 4234.76% to $150.2 million in 2025, then increased by 8.68% to $163.2 million in 2026.
  • Per Business Quant, the three most recent readings for MYRG's Cash & Equivalents are $163.2 million (Q1 2026), $150.2 million (Q4 2025), and $76.2 million (Q3 2025).